Boult Wade Tennant
/test-insights-page

Insights

image
Bulletin

Innovation and Intellectual Property (IP) in sports nutrition: Patents, freedom to operate and commercial strategy

image
Bulletin

UK design law set for refresh: Government unveils plans to modernise protection and tackle bad-faith filings

image
Bulletin

Reform of the UK Clinical Trial Regulations: making the UK a premier destination for clinical research?

image
Bulletin

Patenting for the life sciences industry: Choosing which countries to file in

image
Bulletin

So, it's a date: High Court confirms that the EUTM filing date is the relevant date for assessing absolute grounds for UK trade marks filed under Article 59(1) of the UK-EU Withdrawal Agreement

image
Bulletin

Patenting agrochemicals in Europe: key challenges and opportunities for innovators

image
News

Boult ranked Band 1 by Chambers and Partners UK for 2027

image
News

Boult recognised in Tier 1 by Legal 500 2027

image
Bulletin

Omnia v Sidel appeal confirms: if you intend to opt out, do it early

image
Bulletin

From formulations to ingredients: how consumer behaviour is changing skincare patent strategy

image
Bulletin

The UK-Swiss trade deal: boosting innovation in pharma and biotech

image
Bulletin

The freedom to operate questions every deep-tech company should ask

image
Bulletin

Cheers! UAE opens the door to trade mark registration for alcoholic beverages

image
Bulletin

EPO v UPC – jurisdiction

image
Bulletin

Circular beauty: the chemistry and packaging innovations driving sustainable cosmetics

image
Bulletin

From lab to manufacturing: why scale-up can create new patent opportunities

image
Bulletin

EPO vs UPC: Procedural considerations for EPO oppositions and UPC revocation action proceedings

image
Bulletin

Trade mark pitfalls when launching new products internationally: how Boult’s Spanish team can help you avoid costly mistakes

image
Bulletin

Intellectual property challenges for university spin-outs in chemistry and climate technology

image
Bulletin

G 1/25 decision - description amendments are required, but in more limited cases

MORE

News

image
Boult ranked Band 1 by Chambers and Partners UK for 2027

Boult is pleased to announce that the firm has once again been ranked Band 1 by Chambers and Partners UK for both

image
Boult recognised in Tier 1 by Legal 500 2027

Boult ranked in Tier 1 by Legal 500 in the 2027 PATMA rankings for both patent attorneys and trade mark attorneys.

image
Boult ranked as “Outstanding” by WIPR Patents 2026

Boult is pleased to announce that it has been ranked as “Outstanding” for non-contentious patent matters by the World Intellectual Property Review (WIPR) for 2026.

image
Boult partners have been recognised in the Lexology Index: IP 2026

Boult is proud to be recognised in Lexology Index: IP 2026, with Dr Catherine Wolfe named a Global Elite Thought Leader and multiple partners ranked across the prestigious report.

News

News

image
Boult ranked Band 1 by Chambers and Partners UK for 2027

Boult is pleased to announce that the firm has once again been ranked Band 1 by Chambers and Partners UK for both

image
Boult recognised in Tier 1 by Legal 500 2027

Boult ranked in Tier 1 by Legal 500 in the 2027 PATMA rankings for both patent attorneys and trade mark attorneys.

image
Boult ranked as “Outstanding” by WIPR Patents 2026

Boult is pleased to announce that it has been ranked as “Outstanding” for non-contentious patent matters by the World Intellectual Property Review (WIPR) for 2026.

image
Boult partners have been recognised in the Lexology Index: IP 2026

Boult is proud to be recognised in Lexology Index: IP 2026, with Dr Catherine Wolfe named a Global Elite Thought Leader and multiple partners ranked across the prestigious report.

News